Form 4 for SPRO Spero Therapeutics, Inc.
Accepted 2023-08-30 00:00:00 ET · period of report 2023-08-28 · accession 0000950170-23-045450 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-30 | 2023-08-28 | SPRO | Keutzer Timothy | Chief Development Off | S - Sale | $1.26 | -1,854 | 325.3K | -0.6% | -$2,336 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-28 | S | D | 1,854 | $1.26 | 325,290 | D | — | — |